Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
New Vitalis Pharmacy LLC dba New Vitalis Pharmacy

New Vitalis Pharmacy LLC dba New Vitalis Pharmacy Recalls

All product recalls associated with New Vitalis Pharmacy LLC dba New Vitalis Pharmacy.

Get alerts for this brand

Recall Summary

Total Recalls

719

Past Year

2

Class I (Serious)

47

Most Recent

Jul 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 201–220 of 719 recalls

Testosterone Injection (New Vitalis) – sterility concern (2023)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 13, 2023Nationwide• New Vitalis Pharmacy LLC dba New Vitalis Pharmacy

Norepinephrine Dextrose (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Neonatal TPN Starter Bag 4% (Central Admixture) – sterility risk (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

1...9 101112 13...36

Page 11 of 36Next

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

MSA MSG Comp Solution (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Cardioplegia Solution Low Potassium (Central Admixture) – sterility risk (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Cardioplegia No Potassium (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

HyperLyte CR Injection (Central Admixture) – sterility concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Vasopressin Sodium Chloride Injection (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

EPINEPHrine Sodium Chloride Injection (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Diphenhydramine Sodium Chloride Injection (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Heparin Sodium Chloride (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Vancomycin Sodium Chloride (Central Admixture) – Sterility Issues (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Potassium Phosphate Sodium Chloride (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Neonatal TPN Starter High Calcium (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Vancomycin Sodium Chloride (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Neonatal TPN Starter Bag 3.5% (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Neonatal TPN Starter Amino Acids (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Cardioplegia Solution (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Cardioplegia St Thomas Solution (Central Admixture) – sterility risk (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.

Cardioplegia Induction Solution (Central Admixture) – Sterility Concerns (2023)

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Class IIModerate

FDAApr 28, 2023Nationwide• Central Admixture Pharmacy Services, Inc.